Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Primo N Lara

Showing results (41-50 of 274) with videos related to

Pageof 28
Sort By:
Clinical Lung Cancer|May 8, 2009
Targeted therapies in non-small-cell lung cancer: a paradigm in evolutionRandeep Sangha, Primo N Lara, Philip Mack, et al.
Clinical Lung Cancer|May 16, 2009
Individualizing therapy for non-small-cell lung cancer: a paradigm shift from empiric to integrated decision-makingDavid R Gandara, Primo N Lara, Philip Mack, et al.
Current Treatment Options in Oncology|June 12, 2002
Non-small-cell lung cancer progression after first-line chemotherapyPrimo N Lara, Derick H M Lau, David R Gandara
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2008
Progress in small-cell lung cancer: the lowest common denominatorDavid R Gandara, Primo N Lara, Ronald Natale, et al.
Expert Review of Anticancer Therapy|December 22, 2006
Small-cell carcinoma of the urinary bladder: diagnosis and managementChong-xian Pan, Hongyong Zhang, Primo N Lara, et al.
Current Opinion in Oncology|June 18, 2009
Beyond antiepidermal growth factor receptors and antiangiogenesis strategies for nonsmall cell lung cancer: exploring a new frontierRandeep Sangha, Primo N Lara, Philip C Mack, et al.
Current Opinion in Urology|August 12, 2005
Is the use of anything but MVAC justified in the evidence-based medicine era?Joon-ha Ok, Angelo Cambio, Primo N Lara, et al.
Clinical Lung Cancer|June 13, 2006
Second-line treatment for advanced-stage non-small-cell lung cancer: current and future optionsCheryl Ho, Angela M Davies, Primo N Lara, et al.
World Journal of Urology|June 15, 2007
Prostate cancer and markers of bone metabolism: diagnostic, prognostic, and therapeutic implicationsEric C Nelson, Christopher P Evans, Chong-Xian Pan, et al.
Hematology/Oncology Clinics of North America|April 20, 2004
Treatment of extensive small cell lung cancerAngela M Davies, Primo N Lara, Derick H Lau, et al.
Pageof 28

Showing results (41-50 of 274) with videos related to

Sort By:
Pageof 28
Clinical Lung Cancer|May 8, 2009
Targeted therapies in non-small-cell lung cancer: a paradigm in evolutionRandeep Sangha, Primo N Lara, Philip Mack, et al.
Clinical Lung Cancer|May 16, 2009
Individualizing therapy for non-small-cell lung cancer: a paradigm shift from empiric to integrated decision-makingDavid R Gandara, Primo N Lara, Philip Mack, et al.
Current Treatment Options in Oncology|June 12, 2002
Non-small-cell lung cancer progression after first-line chemotherapyPrimo N Lara, Derick H M Lau, David R Gandara
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2008
Progress in small-cell lung cancer: the lowest common denominatorDavid R Gandara, Primo N Lara, Ronald Natale, et al.
Expert Review of Anticancer Therapy|December 22, 2006
Small-cell carcinoma of the urinary bladder: diagnosis and managementChong-xian Pan, Hongyong Zhang, Primo N Lara, et al.
Current Opinion in Oncology|June 18, 2009
Beyond antiepidermal growth factor receptors and antiangiogenesis strategies for nonsmall cell lung cancer: exploring a new frontierRandeep Sangha, Primo N Lara, Philip C Mack, et al.
Current Opinion in Urology|August 12, 2005
Is the use of anything but MVAC justified in the evidence-based medicine era?Joon-ha Ok, Angelo Cambio, Primo N Lara, et al.
Clinical Lung Cancer|June 13, 2006
Second-line treatment for advanced-stage non-small-cell lung cancer: current and future optionsCheryl Ho, Angela M Davies, Primo N Lara, et al.
World Journal of Urology|June 15, 2007
Prostate cancer and markers of bone metabolism: diagnostic, prognostic, and therapeutic implicationsEric C Nelson, Christopher P Evans, Chong-Xian Pan, et al.
Hematology/Oncology Clinics of North America|April 20, 2004
Treatment of extensive small cell lung cancerAngela M Davies, Primo N Lara, Derick H Lau, et al.
Pageof 28